Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway
International Immunopharmacology · 2023-05 · 118 · 109989
DOI: 10.1016/j.intimp.2023.109989 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-05. Verfasst von Shaoshuai Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fisheries College of Jimei University, Fujian Provincial Key Laboratory of Marine Fishery Resources and Eco-environment, Xiamen, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colitis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Fujian Provincial Department of Science and Technology.
Abstract (Originalsprache)
Isochlorogenic acid A (ICGA-A) is a dicaffeoylquinic acid widely found in various medicinal plants or vegetables, such as Lonicerae japonicae Flos and chicory, and multiple properties of ICGA-A have been reported. However, the therapeutic effect of ICGA-A on colitis is not clear, and thus were investigated in our present study, as well as the underlying mechanisms. Here we found that ICGA-A alleviated clinical symptoms of dextran sodium sulfate (DSS) induced colitis model mice, including disease activity index (DAI) and histological damage. In addition, DSS-induced inflammation was significantly attenuated in mice given ICGA-A supplementation. ICGA-A reduced the fraction of neutrophils in peripheral blood and the infiltration of neutrophils and macrophages in colon tissue, and reduced pro-inflammatory cytokine production and tight junctions in mouse models. Furthermore, ICGA-A down-regulated expression of STAT3 and up-regulated the protein level of IκBα. Our in vitro studies confirmed that ICGA-A inhibited the mRNA expression of pro-inflammatory cytokines. ICGA-A blocked the phosphorylation of STAT3, p65, and IκBα, suppressed the expression STAT3 and p65. In addition, the present study also demonstrated that ICGA-A had no obvious toxicity on normal cells and organs. Taken together, we conclude that ICGA-A mitigates experimental ulcerative colitis (UC) at least in part by inhibiting the STAT3/NF-кB signaling pathways. Hence, ICGA-A may be a promising and effective drug for treating UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fisheries College of Jimei University, Fujian Provincial Key Laboratory of Marine Fishery Resources and Eco-environment, Xiamen, China.
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China.
- Fisheries College of Jimei University, Fujian Provincial Key Laboratory of Marine Fishery Resources and Eco-environment, Xiamen, China. Electronic address: yuanyueli@163.com.
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China. Electronic address: gangsongsd@xmu.edu.cn.
Förderung
- Fujian Provincial Department of Science and Technology
Zitieren
APA
Tang, S., Zhong, W., Li, T., Li, Y., & Song, G. (2023). Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway. International Immunopharmacology, 118, 109989. https://doi.org/10.1016/j.intimp.2023.109989
Vancouver
Tang S, Zhong W, Li T, Li Y, Song G. Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway. International Immunopharmacology. 2023;118:109989. doi:10.1016/j.intimp.2023.109989
BibTeX
@article{Tang2023,
author = {Tang, Shaoshuai and Zhong, Wei and Li, Tingting and Li, Yuanyue and Song, Gang},
title = {Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway},
journal = {International Immunopharmacology},
year = {2023},
volume = {118},
pages = {109989},
doi = {10.1016/j.intimp.2023.109989}
}
EUVIMED